外周动静脉畸形的血管内治疗:血管造影结果与生活质量相关吗?
该单中心回顾性研究纳入2009年1月至2021年12月接受血管内治疗的外周动静脉畸形患者,86例纳入造影分析,61例纳入临床分析。临床缓解率为73.8%(95%CI 0.60-0.84),治疗缓解率为45.9%(95%CI 0.33-0.59),并发症率为8.2%。造影及治疗缓解与生活质量改善无关(分别为p=0.52和p=0.055),临床缓解与生活质量改善相关(p<0.01)。
要点
- 临床缓解率73.8%(95%CI 0.60-0.84),治疗缓解率45.9%(95%CI 0.33-0.59),并发症率8.2%。
- 临床缓解与治疗后生活质量改善相关(p<0.01),造影及治疗缓解与生活质量改善无关(分别为p=0.52和p=0.055)。
- 作者认为不应过度依赖造影反应,应关注症状及生活质量改善。
核心结论
- 血管构筑及造影结果并不总是反映血管内治疗后的生活质量。
- 作者认为不应过度依赖造影反应,应检查患者症状及生活质量的改善。
研究设计与样本
- 单中心回顾性研究,纳入2009年1月至2021年12月接受血管内治疗的外周动静脉畸形患者。
- 86例(男41例[47.7%],女45例[52.3%])纳入造影分析,平均年龄28.44±12.99岁(范围5-61)。
- 61例(男30例[49.2%],女31例[50.8%])纳入临床分析,纳入年龄>12岁且可联系的患者。
- 造影构筑按Yakes分类评估,临床缓解定义为患者最重要的治疗前症状改善,治疗缓解定义为临床缓解加造影缓解>50%。
主要发现
- 临床缓解率为73.8%(95%CI 0.60-0.84),治疗缓解率为45.9%(95%CI 0.33-0.59),并发症率为8.2%。
- 治疗前48例(78.7%)报告生活质量受到负面影响,治疗后48例中33例(68.8%)报告生活质量改善。
- 较高的Schobinger分期与治疗前生活质量负面影响相关(p<0.01),Yakes分型与生活质量无关(p=0.065)。
- 临床缓解与治疗后生活质量改善相关(p<0.01),造影缓解及治疗缓解与生活质量改善无关(分别为p=0.52和p=0.055)。
临床怎么用
- 作者认为不应过度依赖造影反应,应检查患者症状及生活质量的改善。
- 该研究结果有助于临床医生明确外周动静脉畸形血管内治疗中的关注重点及治疗后监测方式。
局限性
- 文献中关于Yakes分类在既往治疗患者中适用性的数据不明确。
- 该研究对Yakes分类在既往治疗患者中的适用性提出质疑。
- 该研究中4型动静脉畸形在既往治疗患者中更常见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with arteriovenous malformations (AVMs) have a lower health-related quality of life (QoL) than the general population. QoL assessment of patients with peripheral AVMs after endovascular treatment is scarce in the literature. Radiologic and clinical outcomes are not always correlated in vascular malformation treatment. This study aimed to investigate the relationship between clinical outcomes, QoL, and angiographic outcomes. MATERIALS AND METHODS: Patients with peripheral AVM that underwent endovascular treatment between January 2009 and December 2021 in a single center were retrospectively evaluated. Patients' characteristics (age, sex), AVM characteristics (Schobinger classification, location, angiographic architecture), previous treatment, treatment characteristics (type of endovascular approach, embolizing agent and number of sessions), percentages of angiographic response, complications, and recurrence were evaluated. The angiographic architecture was evaluated according to the Yakes classification. The questionnaire was applied for evaluation of clinical response and QoL. Patients older than 12 years and those who can be contacted were included in clinical and QoL analysis. Clinical response was defined as improvement in the patient's most important pretreatment symptom. Treatment response was defined as clinical response plus >50% angiographic response. RESULTS: Eighty-six patients (41 males [47.7%], 45 females [52.3%]) were included in angiographic analysis. The mean age was 28.44±12.99 years (range=5-61). Forty-three patients (50%) had previous treatment. The median number of sessions was 2 (range 1-15, InterQuartile Range [IOR]=2). Sixty-one patients (30 males [49.2%], 31 females [50.8%]) were included in clinical analysis. The clinical response rate was 73.8%, 95% confidence interval (CI) [0.60, 0.84]. The treatment response rate was 45.9%, 95% CI [0.33, 0.59]. The complication rate was 8.2%. Before treatment, 48 patients (78.7%) reported a negative impact on their QoL. Thirty-three of 48 patients (68.8%) reported improvement on their QoL after treatment. Higher Schobinger stages were related to a negative impact on QoL before treatment (p<0.01). Yakes types were not related to QoL (p=0.065). Clinical response was related to improvement on QoL after treatment (p<0.01). Angiographic and treatment responses were not related to improved QoL after treatment (p=0.52 and p=0.055, respectively). CONCLUSION: Angiographic architecture and outcomes were not always reflected in QoL after endovascular treatment. CLINICAL IMPACT: This study's findings will help clinicians with what to focus on in AVM treatment and how to monitor patients with peripheral AVM after endovascular treatment. Rather than relying too much on the angiographic response, patients should be checked for symptoms and quality of life improvement. No clear data in the literature regarding the applicability of the Yakes Classification in patients with previous treatment. This study questioned the applicability of the Yakes Classification in patients with previous treatments. In this study, type 4 AVMs were more common in patients with previous treatment.
引用
- Çay F, Eldem G, Sevim GA, et al. Endovascular Treatment of Peripheral Arteriovenous Malformations (AVMs): Do Angiographic Outcomes Relate to the Quality of Life? J Endovasc Ther. 2023. PMID: 37086015. doi:10.1177/15266028231166546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。